{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:08:41Z","timestamp":1791389321841,"version":"4.3.3"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1001\/jamadermatol.2019.4608","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T16:31:36Z","timestamp":1580315496000},"page":"350","source":"Crossref","is-referenced-by-count":62,"title":["Treatment of Netherton Syndrome With Dupilumab"],"prefix":"10.1001","volume":"156","author":[{"given":"Alexa B.","family":"Steuer","sequence":"first","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Cohen","sequence":"additional","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"dlo190027r1","doi-asserted-by":"crossref","DOI":"10.5070\/D32012025055","article-title":"Netherton syndrome with ichthyosis linearis circumflexa and trichorrhexis invaginatum.","volume":"20","author":"Ng","year":"2014","journal-title":"Dermatol Online J"},{"issue":"6","key":"dlo190027r2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jdcr.2017.07.019","article-title":"Infliximab therapy for Netherton syndrome: a case report.","volume":"3","author":"Roda","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"2","key":"dlo190027r3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00441-013-1558-1","article-title":"Netherton syndrome: skin inflammation and allergy by loss of protease inhibition.","volume":"351","author":"Hovnanian","year":"2013","journal-title":"Cell Tissue Res"},{"issue":"2","key":"dlo190027r4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/08923973.2015.1115518","article-title":"A case of Netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels.","volume":"38","author":"Yalcin","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"2","key":"dlo190027r5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2759749\/jamadermatology_steuer_2020_lo_190027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T11:12:39Z","timestamp":1665659559000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2759749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2019.4608","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}